YOUCARE PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.86 CNY | -1.17% |
|
-3.10% | -19.18% |
| Apr. 29 | Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 09 | Youcare Pharma Gets Nod for Registration of Gastric Drug | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 8,694 | 7,539 | 7,539 | - |
| Enterprise Value (EV) 1 | 8,694 | 9,387 | 7,539 | 7,539 |
| P/E ratio | 25.8 x | - | - | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 2.24 x | 1.69 x | 1.47 x |
| EV / Revenue | - | 2.24 x | 1.69 x | 1.47 x |
| EV / EBITDA | - | 23.3 x | 13.7 x | 10.4 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | 2.62 x | 1.94 x | 1.81 x |
| Nbr of stocks (in thousands) | 450,000 | 447,180 | 447,180 | - |
| Reference price 2 | 19.32 | 16.86 | 16.86 | 16.86 |
| Announcement Date | 2/27/23 | 2/24/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | 4,196 | 4,461 | 5,118 |
| EBITDA 1 | - | 402.1 | 551 | 725 |
| EBIT 1 | - | 231.8 | 383 | 537 |
| Operating Margin | - | 5.52% | 8.59% | 10.49% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | 337.8 | - | - | - |
| Net margin | - | - | - | - |
| EPS | 0.7500 | - | - | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 2/27/23 | 2/24/24 | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 4.85% | 8.1% | 10.6% |
| ROA (Net income/ Total Assets) | - | 3.16% | 5.2% | 6.9% |
| Assets | - | - | - | - |
| Book Value Per Share 1 | - | 7.970 | 8.670 | 9.310 |
| Cash Flow per Share | - | - | - | - |
| Capex 2 | - | 495 | 341 | 277 |
| Capex / Sales | - | 11.8% | 7.64% | 5.41% |
| Announcement Date | 2/27/23 | 2/24/24 | - | - |
1CNY2CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.86
CNY
Average target price
28
CNY
Spread / Average Target
+66.07%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.18% | 1.06B | |
| +10.23% | 9.11B | |
| -10.76% | 5.21B | |
| +51.58% | 4.83B | |
| +12.50% | 4.09B | |
| -20.70% | 2.35B | |
| +12.83% | 2.32B | |
| +19.51% | 2.27B | |
| -29.65% | 2.19B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 688658 Stock
- Financials Youcare Pharmaceutical Group Co., Ltd.
